What is Solid Biosciences Inc.'s change in AP?

Solid Biosciences Inc. (SLDB) reported change in AP of $2.32M in Q1 2026.

How has Solid Biosciences Inc.'s change in AP changed year-over-year?

Solid Biosciences Inc.'s change in AP increased by 403.5% year-over-year, from $461K to $2.32M.

What is the long-term trend for Solid Biosciences Inc.'s change in AP?

Over 3 years (2021 to 2025), Solid Biosciences Inc.'s change in AP has grown at a -3.3% compound annual growth rate (CAGR), from $1.21M to -$1.09M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Solid Biosciences Inc. SLDB Change in AP

Change in AP at other companies

Sarepta Therapeutics, Inc.SRPT

-$210.47M-261%

Neurocrine BiosciencesNBIX

-$14.3M-377%

InsmedINSM

-$33.88M+44.9%

Dyne Therapeutics, Inc.DYN

-$4.8M+44.1%

Taysha Gene Therapies, Inc.TSHA

$1.29M+39.7%

Edgewise Therapeutics, Inc.EWTX

$1.45M-49.4%

Other financials

Income statement

See full

Revenue$2.0M-40.6%

Operating income-$57.3M-43.1%

Net income-$56.7M-44.4%

EPS (diluted)-$0.52+11.9%

Balance sheet

See full

Cash & equivalents$297.1M+41.1%

Total debt$20.7M-12.5%

Total equity$374.1M+27.1%

Total assets$422.9M+23.0%

Cash flow

See full

Operating cash flow-$47.2M-48.3%

CapEx$165.0K+31.0%

Free cash flow-$47.4M-48.2%

Valuation

See full

Market cap$872.26M+135%

Enterprise value$595.83M+223%

P/S107.8×-9.9×

Profitability

See full

Operating margin-1,315.2%-4,060pp

Net margin-1,062.3%-251,151pp

FCF margin-1,247.7%-9,569pp

Returns & leverage

See full

Return on equity-57.4%+2.2pp

Debt / equity0.1×0.0×

Current ratio13.1×+2.2×

Where this comes from

Reported directly by Solid Biosciences Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solid Biosciences Inc.'s change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Solid Biosciences Inc.'s change in AP?: Solid Biosciences Inc. (SLDB) reported change in AP of $2.32M in Q1 2026.
How has Solid Biosciences Inc.'s change in AP changed year-over-year?: Solid Biosciences Inc.'s change in AP increased by 403.5% year-over-year, from $461K to $2.32M.
What is the long-term trend for Solid Biosciences Inc.'s change in AP?: Over 3 years (2021 to 2025), Solid Biosciences Inc.'s change in AP has grown at a -3.3% compound annual growth rate (CAGR), from $1.21M to -$1.09M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.